The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms related to this condition, including http://tinyurl.com/hoqq96f
sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent contradictory findings on testosterone therapy prompted Patel and his team to conduct a substantial systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the United States have problems with low testosterone, which occurs when the body doesn't make enough hormones because of a difficulty with the testicles or pituitary gland. This clarifies the unexpected weight gain, obvious aging and decline of energy of somebody.
No clear lower limit of testosterone was confirmed; however 15 ng per dL (0.5 nmol per L) commonly is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all situations and absent or markedly reduced orgasms. As a result of studies in this way, supplemented
with anecdotal evidence, many girls are started on testosterone treatment. Most women can expect to spend one third of their lives in the postmenopausal period. Depression, anger, moodiness, insomnia, and lack of well being are common complaints of postmenopausal women.